Terms: = Ovarian cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568
335 results:
1. Armored TGFβRIIDN ROR1-CAR T cells reject solid tumors and resist suppression by constitutively-expressed and treatment-induced TGFβ1.
Tran TM; Chand Thakuri BK; Nurmukhambetova S; Lee JJ; Hu P; Tran NQ; Steimle B; Dash P; Schneider D
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38609317
[TBL] [Abstract] [Full Text] [Related]
2. Small-molecule inhibitor HI-TOPK-032 improves NK-92MI cell infiltration into ovarian tumours.
Deng M; Yang R; Sun Q; Zhang J; Miao J
Basic Clin Pharmacol Toxicol; 2024 May; 134(5):629-642. PubMed ID: 38501576
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.
Amaria R; Knisely A; Vining D; Kopetz S; Overman MJ; Javle M; Antonoff MB; Tzeng CD; Wolff RA; Pant S; Lito K; Rangel K; Fellman B; Yuan Y; Lu KH; Sakellariou-Thompson D; Haymaker CL; Forget MA; Hwu P; Bernatchez C; Jazaeri AA
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38309721
[TBL] [Abstract] [Full Text] [Related]
4. Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes.
Kalaitsidou M; Moon OR; Sykorova M; Bao L; Qu Y; Sukumaran S; Valentine M; Zhou X; Pandey V; Foos K; Medvedev S; Powell DJ; Udyavar A; Gschweng E; Rodriguez R; Dudley ME; Hawkins RE; Kueberuwa G; Bridgeman JS
Front Immunol; 2023; 14():1256491. PubMed ID: 38022678
[TBL] [Abstract] [Full Text] [Related]
5. Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer.
Verdegaal EME; Santegoets SJ; Welters MJP; de Bruin L; Visser M; van der Minne CE; de Kok PM; Loof NM; Boekestijn S; Roozen I; Westra IM; Meij P; Van der Burg SH; Kroep JR
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 37949617
[TBL] [Abstract] [Full Text] [Related]
6. Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vil-2 cytokine.
Quixabeira DCA; Jirovec E; Pakola S; Havunen R; Basnet S; Santos JM; Kudling TV; Clubb JHA; Haybout L; Arias V; Grönberg-Vähä-Koskela S; Cervera-Carrascon V; Pasanen A; Anttila M; Tapper J; Kanerva A; Hemminki A
Cancer Gene Ther; 2023 Nov; 30(11):1543-1553. PubMed ID: 37666898
[TBL] [Abstract] [Full Text] [Related]
7. BiTE secretion by adoptively transferred stem-like T cells improves FRα+ ovarian cancer control.
McGray AJR; Chiello JL; Tsuji T; Long M; Maraszek K; Gaulin N; Rosario SR; Hess SM; Abrams SI; Kozbor D; Odunsi K; Zsiros E
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37647218
[TBL] [Abstract] [Full Text] [Related]
8. ARTISTRY-7: phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer.
Herzog TJ; Hays JL; Barlin JN; Buscema J; Cloven NG; Kong LR; Tyagi NK; Lanneau GS; Long BJ; Marsh RL; Seward SM; Starks DC; Welch S; Moore KN; Konstantinopoulos PA; Gilbert L; Monk BJ; O'Malley DM; Chen X; Dalal R; Coleman RL; Sehouli J
Future Oncol; 2023 Jul; 19(23):1577-1591. PubMed ID: 37334673
[TBL] [Abstract] [Full Text] [Related]
9. Immune profile of primary and recurrent epithelial ovarian cancer cases indicates immune suppression, a major cause of progression and relapse of ovarian cancer.
Kumar P; Ranmale S; Mehta S; Tongaonkar H; Patel V; Singh AK; Mania-Pramanik J
J Ovarian Res; 2023 Jun; 16(1):114. PubMed ID: 37322531
[TBL] [Abstract] [Full Text] [Related]
10. Effects of leptin on the viability of human ovarian cancer cells and changes in cytokine expression levels.
Dincer F; Atmaca H; Akman L; Oktay LM; Karaca B; Terek MC
PeerJ; 2023; 11():e15246. PubMed ID: 37155466
[TBL] [Abstract] [Full Text] [Related]
11. [Study on construction of c-Met specific CAR-T cells and its killing effect on non-small cell lung carcinoma].
Min JT; Zhang L; Long CR; Fan HL; Li ZZ
Zhonghua Zhong Liu Za Zhi; 2023 Apr; 45(4):322-329. PubMed ID: 37078213
[No Abstract] [Full Text] [Related]
12. Analysis of the Occurrence of Predicative Factors of Chronic Fatigue in Female Patients with cancer of the Reproductive Organs with Respect to Stage of Treatment.
Kłysiak M; Wieder-Huszla S; Branecka-Woźniak D; Karakiewicz-Krawczyk K; Napieracz-Trzosek I; Owsianowska J; Jurczak A; Cymbaluk-Płoska A
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834426
[TBL] [Abstract] [Full Text] [Related]
13. PDP1 Promotes Cell Malignant Behavior and Is Associated with Worse Clinical Features in ovarian cancer Patients: Evidence from Bioinformatics and In Vitro Level.
Song Y; Zhang J; Zhang L; Zhang S; Shen C
Comput Math Methods Med; 2022; 2022():7397250. PubMed ID: 36276992
[TBL] [Abstract] [Full Text] [Related]
14. Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response.
Chen J; Chen S; Dai X; Ma L; Chen Y; Bian W; Sun Y
Front Immunol; 2022; 13():1007326. PubMed ID: 36189254
[TBL] [Abstract] [Full Text] [Related]
15. Generation and Functional Characterization of PLAP CAR-T Cells against Cervical cancer Cells.
Yekehfallah V; Pahlavanneshan S; Sayadmanesh A; Momtahan Z; Ma B; Basiri M
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139135
[TBL] [Abstract] [Full Text] [Related]
16. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.
Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H
Front Immunol; 2022; 13():956224. PubMed ID: 36032075
[TBL] [Abstract] [Full Text] [Related]
17. Herpesvirus entry mediator regulates the transduction of Tregs via STAT5/Foxp3 signaling pathway in ovarian cancer cells.
Shan Y; Zhang B; Chen L; Zhang H; Jiang C; You Q; Li Y; Han H; Zhu J
Anticancer Drugs; 2023 Jan; 34(1):73-80. PubMed ID: 35946515
[TBL] [Abstract] [Full Text] [Related]
18. Preclinical
Li Y; Chen Y; Wei M; Wei C
Front Endocrinol (Lausanne); 2022; 13():845404. PubMed ID: 35464051
[TBL] [Abstract] [Full Text] [Related]
19. Proapoptotic Effect of Icariin on Human ovarian cancer Cells via the NF-[Formula: see text]B/PI3K-AKT Signaling Pathway: A Network Pharmacology-Directed Experimental Investigation.
Gao J; Fu Y; Song L; Long M; Zhang Y; Qin J; Liu H
Am J Chin Med; 2022; 50(2):589-619. PubMed ID: 35114909
[TBL] [Abstract] [Full Text] [Related]
20. TIL expansion with high dose il-2 or low dose il-2 with anti-CD3/anti-CD28 stimulation provides different quality of TIL-expanded T cell clones.
Kongkaew T; Thaiwong R; Tudsamran S; Sae-Jung T; Sengprasert P; Vasuratna A; Suppipat K; Reantragoon R
J Immunol Methods; 2022 Apr; 503():113229. PubMed ID: 35101548
[TBL] [Abstract] [Full Text] [Related]
[Next]
